An interventional study of Thin catheter technique or standard ET-tube for surfactant administration in RDS of Prematurity, Surfactant Deficiency Syndrome Neonatal and Analgesia, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Open to participants aged Up to 2 Days. Per ClinicalTrials.gov, last updated 2025-07-01.
Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This trial evaluates the efficacy and safety of surfactant administration with thin catheter technique together with analgesic premedication in comparison with the established INSURE-strategy. It will provide valuable knowledge to improve clinical methodology and enhance lung protective treatment strategies for preterm infants.
To compare two approaches for surfactant administration during CPAP in preterm infants, the INSURE and the LISA technique, using premedication intubation protocols, and investigate aspects of safety, stress and pain, timely administration of the drug, response in oxygenation and pulmonary outcome.
Our study asks whether (P) among infants born \<32 weeks' gestation with RDS (I) does surfactant administration with LISA and analgesia premedication (C) versus surfactant administration according to the INSURE protocol (O) improve oxygenation and reduce the rate of respiratory failure and need for intubation and mechanical ventilation (T) within 48 hours of the procedure
Primary outcomes:
Safety outcomes:
34 studies on the registry are indexed under Respiratory Distress Syndrome In Premature Infants; 10 are open to participants now.
This study's planned enrollment of 160 is above the median of 45 across 29 interventional studies indexed under Respiratory Distress Syndrome In Premature Infants.
Browse Respiratory Distress Syndrome In Premature Infants studies →Karolinska Institutet is the lead sponsor of 1,150 studies on the registry; 276 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Infants will be excluded from the final analysis if they have a congenital abnormality or condition that might have an adverse effect on breathing or ventilation, including: congenital diaphragmatic hernia; tracheo-oesophageal fistula or cyanotic heart disease.
Surfactant administration by Intubation-surfactant-extubation to CPAP according to standard protocol including premedication with analgesia and sedation.
Procedure: Thin catheter technique or standard ET-tube for surfactant administration
Surfactant administration by thin catheter during spontaneous breathing and continued CPAP according to set protocol including premedication with analgesia.
Procedure: Thin catheter technique or standard ET-tube for surfactant administration
Surfactant administration by intubation with regular ET-tube followed by immediate extubation to CPAP (INSURE) or by thin catheter during spontaneous breathing and continued CPAP.
Oxygenation
Arterial to alveolar ratio (a/A ratio)
Time frame: 24 hours post-procedure
Mechanical ventilation
Need for intubation and mechanical ventilation (MV)
Time frame: 48 hours post-procedure
Duration of ventilatory support
Duration of MV (hours), CPAP (days), Oxygen (days)
Time frame: Discharge
Complications
Incidence of air leaks, bronchopulmonary dysplasia, Systemic hypotension, retinopathy, necrotizing entercolitis, intraventricular hemorrhage, persistent duct
Time frame: Discharge
Mortality
Death or composite outcome death/BPD
Time frame: Discharge
Length of stay
Number of days in NICU and total in neonatal care, including home care
Time frame: Discharge
Delay time
Time from meeting the FiO2 or a/A ratio criteria for surfactant treatment until surfactant administration
Time frame: 24 hours
Intubation attempts
Number of tries before successful intubation/placement of catheter
Time frame: 24 hours
PPV
Positive pressure ventilation during the procedure - yes/no/duration (minutes)
Time frame: 24 hours
Stress and pain
Changes in heart rate, blood pressure and BIIP-scales
Time frame: 24 hours
Plan to share: No
No publications or documents are linked to this record.
Started May 2021 (actual). Primary completion is estimated for Dec 2025, 55 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome In Premature Infants →